A cloud of skepticism has hovered over Abbott for the better part of the year as analysts questioned how well the company could deliver on its promises in the face of certain manufacturing and acquisition-related challenges. But the skeptics were wrong, and CEO Miles White wasn't afraid to gloat about that a bit during the company's third-quarter earnings call.
Medical Device Business
AdvaMed takes a strong stance against India’s price control regulations as Johnson & Johnson reports weak sales of its knee implants in India as a result of the pricing caps.
Rumors of a Smith & Nephew takeout have swirled for years, but two recent business developments make a potential merger seem more likely.
Naglreiter Medical Device Development Organization uses a novel approach to shorten the timeline between medical device concept and device submission.
NuVasive says former exec Patrick Miles schemed for more than a year to disparage the company before jumping ship. Alphatec calls the lawsuit a "frivolous PR stunt."
Developing a medical device and looking to take it to the next level? Join our tour of the MD&M Minneapolis show floor to meet the top medtech innovators in the industry. Below we share the five MD&M Minneapolis exhibitors selected for the tour by the MD+DI editorial team.
The company plans to boost its growth prospects through a $225 million acquisition of Jotec, but disappointing earnings news drove its shares down anyway.
Value-based care and the potential for a corporate tax holiday are a couple of the big topics in the medtech policy spotlight. Here’s how these issues could impact medical device companies.
Medtronic is already bracing for a rough second-quarter earnings report in the aftermath of Hurricane Maria, could California’s wildfires cause further destruction to the company’s bottom line?
Nikhil Murdeshwar, the principal research engineer at Olympus Surgical, shares a few tips on how to develop a low-cost, high-impact R&D budget.
Steve Geist, director of R&D at Edwards Lifesciences’ transcatheter mitral and tricuspid therapies division, talks about how and why innovation can and should be done at a startup pace within larger companies.
Johnson & Johnson plans to shut down Animas Corp., and the nearly 90,000 patients using its insulin pumps will have the option to transfer to Medtronic pumps.
Boston Scientific is acquiring Apama Medical for up to $300 million, a deal that should help the company’s EP business hit its stride.
Medtech startups are struggling to secure funding in the early phases of development. Here’s what large companies, venture capital, and startups can do to combat this troubling trend.